| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
TISSUE THERAPIES LIMITED (TIS)
Stock Code: TIS
Listing Date: 2004-03-19 00:00:00
Website: http://www.tissuetherapies.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Developing biomedical technologies for wound healing and tissue and cell culture.
Address:
66 Eagle Street, Central Plaza Two, Level 11
BRISBANE
QLD 4000
Phone: (07) 3839 9938
Fax: (07) 3839 1486
Executives & Directors
Mr Roger Clarke, Chairman
Dr Steven Mercer, Director, CEO
Mr Gregory Baynton, Director
Prof. David Gardiner, Director
Mr Don Home, Non Exec. Director
Mr Drummond McKenzie, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
|
TIS - Small Caps Forum Interview with Dr Steven Mercer, CEO 
|
Mon, 27 Mar 2006 03:30PM |
|
| Annual General Meeting | Thu, 27 Nov 2008 11:30AM |
|
| Full Year Results | Mon, 18 Aug 2008 | |
| Interim Results | Thu, 7 Feb 2008 | |
| Annual General Meeting | Thu, 18 Oct 2007 10:30AM |
|
| Full Year Results | Thu, 9 Aug 2007 | |
| Interim Results | Thu, 8 Feb 2007 | |
| Annual General Meeting | Thu, 9 Nov 2006 12:00PM |
|
| Full Year Results | Thu, 3 Aug 2006 | |
| Interim Results | Thu, 9 Feb 2006 | |
| Annual General Meeting | Fri, 11 Nov 2005 11:15AM |
TISSUE THERAPIES LIMITED (TIS)
| Appendix 4C -Quarterly Report | Tue, 29 Apr 2008 |
| Positive VitroGro Preclinical Results and Clinical Trial | Wed, 23 Apr 2008 |
| Change of Director`s Interest Notice | Tue, 11 Mar 2008 |
| Change of Director`s Interest Notice | Thu, 6 Dec 2007 |
| Change of CEO`s Interest Notice | Thu, 6 Dec 2007 |
| Appendix 3B | Thu, 29 Nov 2007 |
| CEO Share Purchase | Tue, 27 Nov 2007 |
| Tissue Therapies Appendix 4C - quarterly report | Tue, 30 Oct 2007 |
| New VitroGro Formulation and Patent Applications | Thu, 18 Oct 2007 |
| Chairman`s Address to Shareholders | Thu, 18 Oct 2007 |
| CEO 2007 AGM Address | Thu, 18 Oct 2007 |
| Resolutions Passed 2007 AGM | Thu, 18 Oct 2007 |
| Tissue Therapies 2006 07 Annual Report | Tue, 18 Sep 2007 |
| Tissue Therapies Notice of Annual General Meeting/Proxy Form | Tue, 18 Sep 2007 |
| VitroGro Clinical Trial and Commercial Update | Tue, 18 Sep 2007 |
| Appendix 3B Options Issued to Key Contractors | Thu, 30 Aug 2007 |
| Tissue Therapies` Full-Year Results to 30 June 2007 | Thu, 9 Aug 2007 |
| Appendix 4C - quarterly report | Mon, 30 Jul 2007 |
| Disclosure Notice Issue of Placement Shares | Thu, 26 Jul 2007 |
| Appendix 3B New Issue Announcement | Thu, 26 Jul 2007 |
| Strengthened Financial Position for VitroGro Human Trials | Thu, 26 Jul 2007 |
| Trading Halt | Wed, 25 Jul 2007 |
| CEO SWAPS CASH BONUS FOR OPTIONS | Mon, 9 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.